Find information on thousands of medical conditions and prescription drugs.

Mefloquine

Mefloquine is an orally administered antimalarial drug used as a prophylaxis against and treatment for malaria. It also goes by the trade name LariamTM (manufactured by Roche Pharmaceuticals) and chemical name mefloquine hydrochloride (forumulated with HCl). Mefloquine was developed in the 1970s at the Walter Reed Army Institute of Research in the U.S. as a chemical synthetic similar to quinine. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
Macrodantin
Maprotiline
Marcaine
Marezine
Marijuana
Marinol
Marplan
Matulane
Maxair
Maxalt
Maxolon
MDMA
Measurin
Mebendazole
Mebendazole
Meclofenoxate
Medrol
Mefenamic acid
Mefloquine
Melagatran
Melarsoprol
Meloxicam
Melphalan
Memantine
Metadate
Metamfetamine
Metamizole sodium
Metandienone
Metaxalone
Metenolone
Metformin
Methadone
Methamphetamine
Methaqualone
Metharbital
Methcathinone
Methenamine
Methionine
Methocarbamol
Methohexital
Methotrexate
Methotrexate
Methoxsalen
Methylcellulose
Methyldopa
Methylergometrine
Methylin
Methylphenidate
Methylphenobarbital
Methylprednisolone
Methyltestosterone
Methysergide
Metiamide
Metoclopramide
Metohexal
Metoprolol
Metrogel
Metronidazole
Metyrapone
Mobic
Moclobemide
Modafinil
Modicon
Monopril
Montelukast
Motrin
Moxidectin
Moxifloxacin
Moxonidine
MS Contin
Mucinex
Mucomyst
Mupirocin
Mupirocin
Muse
Mycitracin
Mycostatin
Myfortic
Mykacet
Mykinac
Myleran
Mylotarg
Mysoline
Phentermine
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Side-effects

Like many other drugs, mefloquine has adverse side-effects. It is known to cause severe depression, anxiety, paranoia, nightmares, insomnia, vestibular (balance) damage and central nervous system problems. For a complete list of adverse physical and psychological effects — including suicidal ideation — see the most recent product information. In 2002 the word "suicide" was added to the official product label, though proof of causation has not been established. Since 2003, the FDA has required that patients be screened before mefloquine is prescribed. Anyone taking antidepressants or with a history of psychiatric illness should not take mefloquine. The latest Consumer Medication Guide to Lariam has more complete information.

In the 1990s there were reports in the media that the drug may have played a role in the Somalia Affair, the misbehaviour of Canadian peacekeeping troops on duty in Somalia. There has been similar controversy since three murder-suicides involving Special Forces soldiers at Fort Bragg, N.C., in the summer of 2002. To date more than 19 cases of vestibular damage following the use of mefloquine have been diagnosed by military physicians. The same damage has been diagnosed among business travelers and tourists.

Neurological activity

In 2004, researchers found that mefloquine in adult mice blocks connexins called Cx36 and Cx50. Cx36 is found in the brain and Cx50 is located in the eye lens. Connexins in the brain are believed to play a role in movement, vision and memory.

Chirality and its implications

Mefloquine is a chiral molecule. It contains two asymmetric carbons, which means there are a total of four different enantiomers of the molecule. Mefloquine is currently manufactured and sold as a racemate of the (+/-) R*,S* enantiomers by Hoffman-LaRoche, a Swiss pharmaceutical company. According to some research, the (+) enantiomer is more effective in treating malaria, and the (-) enantiomer specifically binds to adenosine receptors in the central nervous system, which may explain some of its psychotropic effects. Some believe that it is irresponsible for a pharmaceutical company to sell mefloquine as a racemic mixture. It is not known whether mefloquine goes through stereoisomeric switching in vivo.

Advice to travelers

Mefloquine is one of the antimalarial drugs which the August 2005 issue of the CDC Travel Health Yellow Sheet advises travelers in areas with malaria risk — Africa, South America, the Indian subcontinent, Asia, and the South Pacific — to take.

There are virulent strains of malaria that are resistant to one or more anti-malarial drugs; for example, there are mefloquine-resistant strains in Thailand. Travelers are advised to compare current recommendations before selecting an antimalarial drug as the occurrence of drug-resistant strains changes.

Read more at Wikipedia.org


[List your site here Free!]


Trepid and intrepid travelers
From Emerging Infectious Diseases, 8/1/05 by Eric V. Granowitz

When I proposed travel to Africa for our honeymoon, Edy wrinkled her nose. "Why?" she asked.

"It will be wonderful!" I exclaimed. "The people are different. The animals are different. Even the countryside is different. It will be a fantastic getaway. We'll have a great time. Can you think of anyplace better to go?"

"Martha's Vineyard," she answered. "Someplace nearby. I don't want adventure. 1 just want to spend time with you." Sensing my disappointment, she added, "Why not go to Africa for our first anniversary?"

After the wedding and a wonderful trip to Martha's Vineyard, we relocated. I joined a new infectious diseases division, and Edy worked as a self-employed, real estate title examiner. We began planning our safari to Kenya and Tanzania. Edy would see the flamingos of Lake Nakuru, I the wildlife on the Serengeti Plain.

In the months preceding our departure, a New York Times article on political violence in coastal Kenya precipitated anxious telephone calls to the State Department and the US embassy in Nairobi. We ordered DEET, permethrin, a water purification device, and oral rehydration salts. I cringed a little when I wrote a nonrefundable check for the trip. Edy cringed a lot when we received our yellow fever, meningococcal, and hepatitis A immunizations. Mary Jo, the nurse in our travelers' health clinic, went over a list of dietary precautions. When Edy heard from a friend about mefloquine's neuropsychiatric side effects, I could not palliate her fears. Mary Jo was able to counsel her.

The week before departure, Edy sprayed our clothes with permethrin. Another call to the State Department confirmed no recurrence of political violence. We began taking mefloquine. Because I had a history of anaphylaxis to bee venom, I had a prescription filled for an epinephrine autoinjector.

In Nairobi we were greeted by the touring company. A representative drove us through shanty-lined roads to an elegant country club. Next morning, we met our tour group: Noel, an Australian with a quick smile and no previous travel experience, who was embarking on a yearlong trip around the world; Bob, a broad-shouldered Mormon in a sailing T-shirt, who resembled "Mr. Clean"; Paula and Dan, a wealthy couple from Southern California. For someone with an impressive travel resume, Dan appeared anxious. The source of his anxiety was Paula. While her eyes were filled with life, her body was not. Her ill-fitting wig, pale complexion, and unsure gait reminded me of patients on the oncology ward at the hospital. To avoid being identified as the tour physician, I introduced myself as assistant professor at a New England university.

While the rest of us tried to get over jetlag, Edy and Dan braved a thunderstorm to take a shuttle downtown. The next morning, I awoke to find Edy with her hands folded over her abdomen and a worried expression on her face. "Ice cream sundae," she admitted, when I asked what she had eaten in Nairobi. After a dose of ciprofloxacin and loperamide, Edy made her way to the jeep. Her eyelids drooped when the guide announced the 8-hour drive to our destination. Although Edy made it to the game park uneventfully, her dining partner was not as fortunate. Despite antimicrobial treatment for probable salmonellosis, Dan had fever and explosive diarrhea. Noel experienced recurrent emesis and diarrhea, probably from brushing his teeth with tap water. Forced by these circumstances to reveal my identity as an infectious disease specialist, I now became "the doctor." Dan and Noel recovered uneventfully, but my vacation changed irrevocably.

Most of our meals were now punctuated by, "Can I eat this?" The query was directed at me. "Because this is a 5-star hotel," I responded, "that's probably okay. But generally, if the food hasn't been cooked, boiled, or peeled, don't eat it." The follow-up question was, "Would you eat it?" Being conservative, 1 smiled and shook my head when they pointed to the salad.

When our tour group grew, the questions multiplied. People asked about vaccinations, although almost everyone had been properly immunized. There was a case of doxycycline-associated photosensitivity in a woman who did not apply sunscreen. Two people stopped malaria chemoprophylaxis because of perceived adverse effects. Another woman told me she was glad a doctor was on the trip so she didn't have to be so careful with food. I was changing, from wanting to help to becoming resentful. My companions seemed unwilling to follow simple precautions, yet expected care when their "indiscretions" made them ill.

A new companion, Lester, got travelers' diarrhea. I suggested bottled water and beverages without ice cubes. Before I could even ask, Edy reached into her knapsack and gave Lester ciprofloxacin and loperamide. That evening, I heard Lester's wife screaming my name. I arrived to find Edy's patient unconscious and held upright by his friends. After we moved Lester into the Trendelenburg position, he quickly regained consciousness. The next morning, Lester was off for a ride in a hot air balloon.

Six months before our trip, Paula had undergone a stein cell transplant for non-Hodgkin's lymphoma. She had since experienced recurrent emesis and anemia unresponsive to erythropoietin, now complicated by lightheadedness and near syncope. When Dan asked if they should abandon the tour, I recommended they return home. They remained on safari. Eventually, hematocrit of 13 at an altitude of 5,000 ft proved too much for Paula. She was flown to the hospital for emergency transfusion.

Finally, our trip concluded, Edy and I settled in for the flight home. My thoughts were a menagerie of lions, elephants, rhinoceroses, giraffes, oryxes, ostriches, and vultures. I relived the experience of watching a pack of hyenas tear the entrails out of a wild-eyed wildebeest. In spite of every effort to free itself, the wildebeest could not escape. Similarly, even on vacation, I could not escape being a doctor. My personal life had once again been compromised by my professional responsibilities.

I fell asleep. Some time later, Edy roused me with a nudge. "I was proud of the way you took care of people," she declared. This was the first time Edy had seen me practice medicine, and she had enjoyed watching me attend to our group. Her comments reminded me that caring for others was a privilege.

Before I could express these thoughts, Edy continued, "This was a great vacation. Where do you want to go next year? Thailand? It would be wonderful. The people are different. The animals are different. Even the countryside is different. It will be a fantastic getaway. We'll have a great time. Can you think of anyplace better to go?"

"Martha's Vineyard," I said.

[FIGURE OMITTED]

Acknowledgment

I thank Parminder Bolina for constructive comments.

Eric V. Granowitz *

* Baystate Medical Center and Tufts University School of Medicine, Springfield, Massachusetts, USA

Address for correspondence: Eric V. Granowitz, Infectious Disease Division, Baystate Mcdical Center, 759 Chestnut St, Springfield, MA 01199, USA; fax: 413-794-4199; email: eric.granowitz@bhs.org

COPYRIGHT 2005 U.S. National Center for Infectious Diseases
COPYRIGHT 2005 Gale Group

Return to Mefloquine
Home Contact Resources Exchange Links ebay